Market Place
Sourcing Support
Aruvant Announces Data Presentation at EHA 2022
10 Jun 2022 //
PRNEWSWIRE
Aruvant Announces Oral Presentation at ASGCT
12 May 2022 //
PRNEWSWIRE
Aruvant to Participate in Multiple Conferences This Spring
19 Apr 2022 //
PRNEWSWIRE
Aruvant Announces ARU-1801 Data to be Presented at the 63rd (ASH)
04 Nov 2021 //
PRNEWSWIRE
Aruvant Partners with Aldevron Collaboration to Manufacture Pipeline Products
16 Jun 2021 //
PRNEWSWIRE
Aruvant Announces ARU-2801 Data Publications and Advocacy Partnership
15 Jun 2021 //
PRNEWSWIRE
Aruvant Announces ARU-2801 Data Publications and Advocacy Partnership
14 Jun 2021 //
BIOSPACE
Aruvant Announces Oral Presentation at 15th Annual Sickle Cell Disease Research
27 May 2021 //
PRNEWSWIRE
Aruvant Announces Data Presentation on Lead Program ARU-1801 at EHA
12 May 2021 //
PRNEWSWIRE
Aruvant Announces Oral Data Presentation at (ASGCT) 24th Annual Meeting
27 Apr 2021 //
PRNEWSWIRE
Aruvant Announces the European Medicines Agency (EMA) Granted Medicines
03 Feb 2021 //
PRNEWSWIRE
Aruvant partners with Lonza to manufacture sickle cell disease treatment
19 Jan 2021 //
PHARMACEUTICAL-TECHNOLOGY
Aruvant Chooses Lonza to MFG ARU-1801, a Potentially Curative Sickle Cell
18 Jan 2021 //
BIOSPACE
Aruvant`s Data Presented in Oral Presentation at the 62nd (ASH)
07 Dec 2020 //
PRNEWSWIRE
Aruvant`s Data Presented in Oral Presentation at the 62nd (ASH)
07 Dec 2020 //
PRNEWSWIRE
Aruvant to Participate in SVB Leerink`s Biopharma Private Company
01 Dec 2020 //
PRNEWSWIRE
Aruvant Receives Orphan Designation from European Medicines Agency
16 Nov 2020 //
PRNEWSWIRE
Aruvant Receives Orphan Designation from EMA for Gene Therapy ARU-1801
16 Nov 2020 //
PRNEWSWIRE
Aruvant Announces Updated Data to be Presented in Oral Presentation of ARU-1801
04 Nov 2020 //
PRNEWSWIRE
Aruvant Appoints Dr. Palaniappan as Chief Technology Officer
01 Jun 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.